<DOC>
	<DOC>NCT01747083</DOC>
	<brief_summary>This study is designed to investigate the food-effects on FDC(gemigliptin/metformin HCl sustained release) 50/1000mg(25/500mg x 2tablets)</brief_summary>
	<brief_title>Food-Effect Bioavailability Study of FDC(Gemigliptin/Metformin HCl Sustained Release) 50/1000mg(25/500mg x 2tablets)</brief_title>
	<detailed_description />
	<mesh_term>Metformin</mesh_term>
	<criteria>Age between 20 to 45, healthy male subjects(at screening) BMI between 19.0 27.0 FPG 70125mg/dL glucose level(at screening) Subject who totally understand the progress of this clinical trials, make decision by his free will, and signed a consent form to follow the progress. Subject who has past or present history of any diseases following below.(liver including hepatitis virus carrier, kidney, Neurology,immunology,pulmonary,endocrine,hematooncology,cardiology,mental disorder.) Subject who had GI tract disease or(ulcer, acute or chronic pancreatitis) surgery.(appendectomy, hernioplasty are not included) Subject who had drug hypersensitivity reaction.(Aspirin, antibiotics) Subject who already participated in other trials in 90 days Subject who had whole blood donation in 60 days, or component blood donation in 30 days or transfusion in 30 days currently. Smokers.(but, if the subject did'nt smoke in 3months, can participate the trial)</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>